Roche's Alecensa delivers unprecedented Phase III results for people with ALK-positive early-stage lung cancer
World Pharma News | Sep 09, 2023
Researchers pinpoint protein tied to drug resistance in patients with lung cancer
MedicalXpress Breaking News-and-Events | Jul 18, 2023
Combination cancer therapies can shrink tumours and improve outcome in advanced non-small lung cancer: Clinical trial
MedicalXpress Breaking News-and-Events | Jul 15, 2023
Targeting telomeres could be an effective therapeutic strategy against lung cancer, according to study
MedicalXpress Breaking News-and-Events | May 27, 2023
New study sheds light on incidental findings in lung cancer screening
MedicalXpress Breaking News-and-Events | May 11, 2023
AI could help doctors diagnose lung cancer
MedicalXpress Breaking News-and-Events | May 04, 2023
Lung cancer's molecular features shed light on immunotherapy response
MedicalXpress Breaking News-and-Events | Apr 21, 2023
Genetic clues reveal lung cancer's next move
MedicalXpress Breaking News-and-Events | Apr 15, 2023
Researchers assemble comprehensive atlas of gene mutations in human tissue
MedicalXpress Breaking News-and-Events | Apr 15, 2023